Female Urogenital Diseases and Pregnancy Complications

217 trials 111 recruiting

Filter these 217 trials by phase, country and sponsor.

Open in Search →

Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle… Not authorised

2023-504616-15-00 Infertility 5
A Phase I First-in-Human Dose Escalation Trial to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2Po… Not authorised

2025-521052-35-00 Patients with HER2Positive Advanced Breast Cancer 7
A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of k… Not authorised

2022-501389-23-00 end-stage renal disease or otherwise an insufficient ki 4
Open label, four-period, two-sequence, fully replicated, randomized, single dose pivotal study for the assessment of bioequivalence between … Not authorised

2023-505335-12-00 Not applicable. The study will be conducted on healthy 2
TRAP study: Testosterone for Androgen Receptor Polymorphism. Not authorised

2024-510596-37-00 low ovarian reserve according to Bologna criteria and c 6
The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertility Not authorised

2022-500792-31-00 Endometriosis in women with involuntary infertility 6
The MEMORINEPH study: Memory B cell level-based tailored treatment with Rixathon in children with complicated forms of steroid-sensitive Nep… Not authorised

2024-511214-20-00 Complicated forms of idiopathic steroid-sensitive nephr 4
Comparison of two prophylactic antibiotic regimens in case of preterm prelabor rupture of membranes before 34 weeks of gestation: a randomiz… Pending

2025-520842-31-00 Population of study participants Pregnant women with PP 5
MERCURE study: MEthotrexate in ReCurrent dVIN Pending

2025-524373-17-00 dVIN caused by Lichen Sclerosus 6
The REFINE study Pending

2025-522133-66-00 Autoimmune Premature Ovarian Insufficiency 5
A Participant- and Investigator--Blinded, Placebo-Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate… Pending

2025-520978-18-00 Chronic Kidney Disease 1
Efficacy of certolizumab in women with unexplained recurrent implantation failure: a double-blind randomized controlled trial (CERTIFY) Pending

2024-511869-11-00 Adult women with recurrent implantation failures (RIF) 5
CARESS Study: Cabergoline for the Reduction of Endometriosis Symptoms and Lesion Size Pending

2025-522812-18-00 Endometriosis 11
MENOPUR and REKOVELLE in Women UnderGoing an assisted reproductive technology cycle Pending

2022-500308-23-00 Infertility in women undergoing assisted reproductive t 11
Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone ther… Pending

2024-520435-33-00 Climacteric symptoms 5
Vaginal administration of selective estrogen receptor modulator (Tamoxifen) treatment to improve sexual function for women with breast cance… Pending

2024-517315-69-00 Vulvovaginal atrophy symptoms 5
Food effect and single- and multiple-ascending dose clinical trial of DF2755A in healthy participants Pending

2025-522935-32-00 interstitial cystitis/bladder pain syndrome 3
COLOMBE - A multicentre, single arm, phase 1/2 study, aiming to assess the safety and efficacy of nivolumab and imiquimod combination in vul… Pending

2025-524759-29-00 Vulvar Squamous Cell Carcinoma (VSCC) patients 9
AUTOP 2 : Screen-and-treat strategy for vaginal flora abnormalities by molecular biology in pregnant women at high risk of preterm birth: A … Pending

2023-509421-41-03 Bacterial vaginosis 5
A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of k… Pending

2022-501389-23-02 end-stage renal disease or otherwise an insufficient ki 4
Trial evaluating the pharmacodynamics of two dosing regimens of nolasiban Pending

2025-524896-22-00 Women with an indication for IVF/ICSI 4
Exogenous progesterone as ovulation trigger – a pilot study Pending

2025-523850-15-00 Infertility 6
Treatment of adenomyosis in women of reproductive age. Pending

2025-523076-23-00 Adenomyosis 4
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to the Renal Pelvis (LUNAR) Pending

2024-514360-70-00 Low-grade upper track urothelial carcinoma (LG-UTUC) 9